Matches in SemOpenAlex for { <https://semopenalex.org/work/W4291596941> ?p ?o ?g. }
- W4291596941 endingPage "11387" @default.
- W4291596941 startingPage "11365" @default.
- W4291596941 abstract "Herein, we report a series of selective sub-nanomolar inhibitors against butyrylcholinesterase (BChE). These compounds, bearing a novel N-benzyl benzamide scaffold, inhibited BChE with IC50 from picomolar to nanomolar. The inhibitory activity was confirmed by the surface plasmon resonance assay, showing a sub-nanomolar KD value, which revealed that the compounds exert the inhibitory effect through directly binding to BChE. Several compounds showed neuroprotective effects verified by the oxidative damage model. Furthermore, the safety of S11-1014 and S11-1033 was demonstrated by the in vivo acute toxicity test. In the behavior study, 0.5 mg/kg S11-1014 or S11-1033 exhibited a marked therapeutic effect, which was almost equal to the treatment with 1 mg/kg rivastigmine, against the cognitive impairment induced by Aβ1-42. The pharmacokinetics studies characterized the metabolic stability of S11-1014. Thus, N-benzyl benzamide inhibitors are promising compounds with drug-like properties for improving cognitive dysfunction, providing a potential strategy for the treatment of Alzheimer's disease." @default.
- W4291596941 created "2022-08-15" @default.
- W4291596941 creator A5006795010 @default.
- W4291596941 creator A5013527186 @default.
- W4291596941 creator A5014378227 @default.
- W4291596941 creator A5027411179 @default.
- W4291596941 creator A5029977604 @default.
- W4291596941 creator A5031755924 @default.
- W4291596941 creator A5031993303 @default.
- W4291596941 creator A5040558103 @default.
- W4291596941 creator A5044301848 @default.
- W4291596941 creator A5044488872 @default.
- W4291596941 creator A5045940535 @default.
- W4291596941 creator A5064248942 @default.
- W4291596941 creator A5068267027 @default.
- W4291596941 creator A5069744037 @default.
- W4291596941 creator A5073216396 @default.
- W4291596941 creator A5083787292 @default.
- W4291596941 creator A5088342433 @default.
- W4291596941 creator A5088889008 @default.
- W4291596941 date "2022-08-15" @default.
- W4291596941 modified "2023-10-18" @default.
- W4291596941 title "<i>N</i>-Benzyl Benzamide Derivatives as Selective Sub-Nanomolar Butyrylcholinesterase Inhibitors for Possible Treatment in Advanced Alzheimer’s Disease" @default.
- W4291596941 cites W1546531859 @default.
- W4291596941 cites W1841850981 @default.
- W4291596941 cites W1971048984 @default.
- W4291596941 cites W1973872488 @default.
- W4291596941 cites W1994067502 @default.
- W4291596941 cites W1999314606 @default.
- W4291596941 cites W2002181764 @default.
- W4291596941 cites W2002559713 @default.
- W4291596941 cites W2006568013 @default.
- W4291596941 cites W2026976753 @default.
- W4291596941 cites W2037328302 @default.
- W4291596941 cites W2042614919 @default.
- W4291596941 cites W2045800802 @default.
- W4291596941 cites W2047568911 @default.
- W4291596941 cites W2075171948 @default.
- W4291596941 cites W2075304800 @default.
- W4291596941 cites W2098437204 @default.
- W4291596941 cites W2103440561 @default.
- W4291596941 cites W2104227586 @default.
- W4291596941 cites W2142587255 @default.
- W4291596941 cites W2169867811 @default.
- W4291596941 cites W2358666620 @default.
- W4291596941 cites W2488182475 @default.
- W4291596941 cites W2510806376 @default.
- W4291596941 cites W2567222259 @default.
- W4291596941 cites W2597990638 @default.
- W4291596941 cites W2739721831 @default.
- W4291596941 cites W2770001293 @default.
- W4291596941 cites W2770975816 @default.
- W4291596941 cites W2774623109 @default.
- W4291596941 cites W2906136049 @default.
- W4291596941 cites W2974532116 @default.
- W4291596941 cites W2980601903 @default.
- W4291596941 cites W3046194558 @default.
- W4291596941 cites W3093934717 @default.
- W4291596941 cites W3457550 @default.
- W4291596941 cites W4213187162 @default.
- W4291596941 cites W4248650858 @default.
- W4291596941 doi "https://doi.org/10.1021/acs.jmedchem.2c00944" @default.
- W4291596941 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35969197" @default.
- W4291596941 hasPublicationYear "2022" @default.
- W4291596941 type Work @default.
- W4291596941 citedByCount "10" @default.
- W4291596941 countsByYear W42915969412022 @default.
- W4291596941 countsByYear W42915969412023 @default.
- W4291596941 crossrefType "journal-article" @default.
- W4291596941 hasAuthorship W4291596941A5006795010 @default.
- W4291596941 hasAuthorship W4291596941A5013527186 @default.
- W4291596941 hasAuthorship W4291596941A5014378227 @default.
- W4291596941 hasAuthorship W4291596941A5027411179 @default.
- W4291596941 hasAuthorship W4291596941A5029977604 @default.
- W4291596941 hasAuthorship W4291596941A5031755924 @default.
- W4291596941 hasAuthorship W4291596941A5031993303 @default.
- W4291596941 hasAuthorship W4291596941A5040558103 @default.
- W4291596941 hasAuthorship W4291596941A5044301848 @default.
- W4291596941 hasAuthorship W4291596941A5044488872 @default.
- W4291596941 hasAuthorship W4291596941A5045940535 @default.
- W4291596941 hasAuthorship W4291596941A5064248942 @default.
- W4291596941 hasAuthorship W4291596941A5068267027 @default.
- W4291596941 hasAuthorship W4291596941A5069744037 @default.
- W4291596941 hasAuthorship W4291596941A5073216396 @default.
- W4291596941 hasAuthorship W4291596941A5083787292 @default.
- W4291596941 hasAuthorship W4291596941A5088342433 @default.
- W4291596941 hasAuthorship W4291596941A5088889008 @default.
- W4291596941 hasConcept C112705442 @default.
- W4291596941 hasConcept C126322002 @default.
- W4291596941 hasConcept C150903083 @default.
- W4291596941 hasConcept C181199279 @default.
- W4291596941 hasConcept C185592680 @default.
- W4291596941 hasConcept C202751555 @default.
- W4291596941 hasConcept C207001950 @default.
- W4291596941 hasConcept C25498285 @default.
- W4291596941 hasConcept C2776332859 @default.
- W4291596941 hasConcept C2777752497 @default.
- W4291596941 hasConcept C2778816929 @default.